Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.08T, Eli Lilly(LLY) trades at $1,143.96. The stock has a price-to-earnings ratio of 39.32 and currently yields dividends of 0.58%.
During the trading session on 2026-10-01, Eli Lilly(LLY) shares reached a daily high of $1,165.00 and a low of $1,141.50. At a current price of $1,143.96, the stock is +0.2% higher than the low and still -1.8% under the high.
Trading activity shows a volume of 392.48K, compared to an average daily volume of 2.49M.
The stock's 52-week range extends from a low of $763.30 to a high of $1,292.65.
The stock's 52-week range extends from a low of $763.30 to a high of $1,292.65.
LLY News
...
Foghorn Therapeutics (FHTX) announced that, following a review of clinical data from the Phase 1 dose escalation trial of FHD-909, Foghorn and Lilly (LLY) have...
Eli Lilly (LLY) announced results from post-hoc analyses of ATTAIN-1 showing that Foundayo – orforglipron – was associated with significant reductions in predic...
Analyst ratings
84%
of 32 ratingsMore LLY News
Eli Lilly (LLY) announced detailed results from the Phase 3 ACHIEVE-4 trial evaluating the efficacy and safety of Foundayo – orforglipron – vs. titrated insulin...
Eli Lilly (LLY Quick QuoteLLY - Free Report) closed at $1,157.08 in the latest trading session, marking a -2.33% move from the prior day. The stock's chan...
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Amazon In New Base 9/30/2026 Among the best stocks in earnings performance, highly rated...
Pharmaceutical giant Eli Lilly and Co. (NYSE:LLY) reported positive data from two late-stage clinical trials, showcasing substantial progress in treatments for...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly And Company (LLY) is running a Phase 2b study called “A Study of Cla...
Key Points TRIUMPH-2 contains retatrutide, a triple agonist weight loss drug. Triple-agonist drugs attempt to suppress appetite, lower blood sugar, and increa...
Eli Lilly’s (LLY) stock is rising on Sept. 30 after the pharmaceutical giant reported that “EloraTZP,” a combination regimen containing its popular weight-loss...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.